Cargando…
Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review
Idiopathic pulmonary fibrosis (IPF) is a severe interstitial lung disease; although the recent introduction of two anti-fibrosis drugs, pirfenidone and Nidanib, have resulted in a significant reduction in lung function decline, IPF is still not curable. Approximately 2-20% of patients with IPF have...
Autores principales: | Ding, Dongyan, Gao, Rong, Xue, Qianfei, Luan, Rumei, Yang, Junling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969503/ https://www.ncbi.nlm.nih.gov/pubmed/36860670 http://dx.doi.org/10.7150/ijms.80358 |
Ejemplares similares
-
Protective role of zinc in the pathogenesis of respiratory diseases
por: Luan, Rumei, et al.
Publicado: (2022) -
Anti-PD-1/PD-L1 and anti-CTLA-4 associated checkpoint inhibitor pneumonitis in non-small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
por: Hu, Xiao, et al.
Publicado: (2023) -
The protective effect of natural medicines against excessive inflammation and oxidative stress in acute lung injury by regulating the Nrf2 signaling pathway
por: Luan, Rumei, et al.
Publicado: (2022) -
The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
por: Tirelli, Claudio, et al.
Publicado: (2022) -
The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B
por: Zhang, Qinghua, et al.
Publicado: (2019)